# NHS Framework for North of England Branded Medicines - Tranche A and Annual Tranche\.

> Tender notice from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS England](/buyers/nhs-england/contract-awards)
- Tender value: £326,826,824
- Published: 23 September 2022
- Planned start: 1 March 2023
- Planned end: 28 February 2025
- Stage: open_tender
- Procurement category: goods
- Notice ID: a356c233-8f29-49a8-9379-2e35033c73db-574320
- OCID: ocds-b5fd17-e8e05740-fcac-48ab-8362-21ec59e4d8cd

## Description

NHS Framework for North of England Branded Medicines - Tranche A and Annual Tranche\. Offer reference number: CM/PHR/20/5606 CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A\. Period of framework: 1 March 2023 to 28 February 2025 with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 24 months CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche\. Period of framework: 1 March 2023 to 29 February 2024 with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 12 months CM/PHR/20/5606/03 - NHS National Framework Agreement for the supply of Risankizumab for South of England and London\. Period of framework: 1 March 2023 to 31 August 2023 with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 6 months

## Related contract awards

- [Identity Access Management - Service Adoption and Enablement](/contracts/ocds-b5fd17-08ebad6c-84fb-4e62-9afd-d06d220dd3a5): NHS England
- [OutSystems licenses for MAPPTI \(AP&P\)](/contracts/ocds-b5fd17-521fbf90-6e93-4366-b3bc-47aa2efd447d): NHS England
- [Provision of national e-portfolio 26/27](/contracts/ocds-b5fd17-7e027849-39ea-4eb8-8eb0-3b38f18dcca4): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/a356c233-8f29-49a8-9379-2e35033c73db-574320)